SHL logo

Sonic Healthcare Limited Stock Price

ASX:SHL Community·AU$11.8b Market Cap
  • 3 Narratives written by author
  • 4 Comments on narratives written by author
  • 115 Fair Values set on narratives written by author

SHL Share Price Performance

AU$0
-27.65 (-100.00%)
AU$26.15
Fair Value
AU$0
-27.65 (-100.00%)
Price AU$0

SHL Community Narratives

AnalystConsensusTarget·
Fair Value AU$26.15 8.8% undervalued intrinsic discount

Digital Pathology And Global Expansion Will Define Healthcare

1users have liked this narrative
4users have commented on this narrative
62users have followed this narrative
AnalystLowTarget·
Fair Value AU$23 3.7% overvalued intrinsic discount

Genetics And Radiology Services Will Support Steady Margins And Fairly Priced Prospects

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystHighTarget·
Fair Value AU$33.3 28.3% undervalued intrinsic discount

Radiology And Genetics Demand Will Transform This Diagnostics Consolidator Over The Next Decade

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AU$33.3
28.3% undervalued intrinsic discount
Revenue
9.64% p.a.
Profit Margin
7.26%
Future PE
21.02x
Price in 2029
AU$40.42
AU$23
3.7% overvalued intrinsic discount
Revenue
8.06% p.a.
Profit Margin
5.71%
Future PE
19.3x
Price in 2029
AU$27.92

Trending Discussion

Updated Narratives

SHL logo

SHL: Dividend Clarity And Steady Margins Will Support A Fair Future Multiple

Fair Value: AU$26.15 8.8% undervalued intrinsic discount
62 users have followed this narrative
4 users have commented on this narrative
0 users have liked this narrative
SHL logo

Radiology And Genetics Demand Will Transform This Diagnostics Consolidator Over The Next Decade

Fair Value: AU$33.3 28.3% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SHL logo

Genetics And Radiology Services Will Support Steady Margins And Fairly Priced Prospects

Fair Value: AU$23 3.7% overvalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value average dividend payer.

2 Risks
2 Rewards

Sonic Healthcare Limited Key Details

AU$10.4b

Revenue

AU$7.0b

Cost of Revenue

AU$3.4b

Gross Profit

AU$2.9b

Other Expenses

AU$539.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.09
32.84%
5.18%
47.6%
View Full Analysis

About SHL

Founded
1934
Employees
45000
CEO
James Newcombe
WebsiteView website
www.sonichealthcare.com

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Recent SHL News & Updates

Recent updates

No updates